A Light-Activated Theranostic Nanoagent for Targeted Macrophage Ablation in Inflammatory Atherosclerosis

Small - Germany
doi 10.1002/smll.201000596
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Targeted Therapeutics in Inflammatory Atherosclerosis

English

A Multifunctional Theranostic Nanoagent for Dual-Mode Image-Guided HIFU/Chemo- Synergistic Cancer Therapy

Theranostics
MedicineToxicologyPharmaceuticsPharmacology
2016English

Macrophage Metabolism in Atherosclerosis

FEBS Letters
GeneticsCell BiologyMolecular BiologyBiochemistryStructural BiologyBiophysics
2017English

PET/CT Imaging of Chemokine Receptors in Inflammatory Atherosclerosis Using Targeted Nanoparticles

Journal of Nuclear Medicine
MedicineNuclear MedicineRadiologyImaging
2016English

Regulation of Macrophage Immunometabolism in Atherosclerosis

Nature Immunology
AllergyImmunology
2018English

Role of Macrophage-Derived Histamine in Atherosclerosis— Chronic Participation in the Inflammatory Response &Mdash;

Journal of Atherosclerosis and Thrombosis
BiochemistryInternal MedicineCardiovascular MedicineCardiology
2004English

Atherosclerosis: A Classic Inflammatory Disease

International Journal of Immunopathology and Pharmacology
AllergyImmunologyPharmacology
2011English

A Macrophage Receptor for Apolipoprotein B48: Cloning, Expression, and Atherosclerosis

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2000English

Microenviromental Factors Controlling Macrophage Polarization in Atherosclerosis

Endocrinology & Metabolic Syndrome
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy